Medtronic hits regulatory milestone for TAVI devices

05/24/2013 | Medical Device & Diagnostic Industry online

Medtronic has obtained CE mark approval in Europe for its CoreValve and CoreValve Evolut transcatheter aortic valve implantation devices to be used in valve-in-valve procedures, which are meant to replace degenerated surgical aortic valves in patients who are at high risk for open-heart surgery. The CoreValve TAVI device is still undergoing clinical studies in the U.S.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA